Anastasia Ivanova

发表

GEOTECHNICAL MONITORING OF BUILDINGS AND STRUCTURES FOR THE CONTROL AND CONSTRUCTION SAFETY

Anastasia Ivanova, Tatiana Solovieva, Tatiana Bugakova, 2019 .

CRM2DIM: A SAS macro for implementing the dual-agent Bayesian continual reassessment method

Anastasia Ivanova, Mohamed Amine Bayar, Gwénaël Le Teuff, 2019, Comput. Methods Programs Biomed..

Selection of the initial design for the two-stage continual reassessment method

Anastasia Ivanova, Xiaoyu Jia, Shing M Lee, 2017, Journal of biopharmaceutical statistics.

Adjusting for observable selection bias in block randomized trials

Anastasia Ivanova, Vance W Berger, Robert C Barrier, 2005, Statistics in medicine.

THE MAXIMAL PROCEDURE FOR PATIENT ALLOCATION IN RANDOMIZED CLINICAL TRIALS

Anastasia Ivanova, Vance W. Berger, Erin Y. Wei, 2001 .

Minimizing predictability while retaining balance through the use of less restrictive randomization procedures

Anastasia Ivanova, Vance W Berger, Maria Deloria Knoll, 2003, Statistics in medicine.

Up‐and‐Down and Escalation Designs

Anastasia Ivanova, Assaf P. Oron, 2014 .

A non‐parametric approach to the design and analysis of two‐dimensional dose‐finding trials

Kai Wang, Anastasia Ivanova, A. Ivanova, 2004, Statistics in medicine.

A Birth and Death Urn for Ternary Outcomes: Stochastic Processes Applied to Urn Models

Nancy Flournoy, Anastasia Ivanova, N. Flournoy, 2000 .

Adaptive designs for phase I trials 1

Anastasia Ivanova, 2016 .

Dose Escalation and Up-and-Down Designs

Anastasia Ivanova, 2007 .

Improved up‐and‐down designs for phase I trials

Anastasia Ivanova, Sri Gopal Mohanty, Aliakbar Montazer-Haghighi, 2003, Statistics in medicine.

Two-stage designs for Phase 2 dose-finding trials.

Anastasia Ivanova, Yevgen Tymofyeyev, Changfu Xiao, 2012, Statistics in medicine.

Comparing oncology clinical programs by use of innovative designs and expected net present value optimization: Which adaptive approach leads to the best result?

Christopher Jennison, Guochen Song, Anastasia Ivanova, 2017, Journal of biopharmaceutical statistics.

Continual reassessment method with regularization in phase I clinical trials.

Xiang Li, Anastasia Ivanova, Kevin Liu, 2020, Journal of biopharmaceutical statistics.

Response-Adaptive Designs

Feifang Hu, Anastasia Ivanova, A. Ivanova, 2018 .

Methods for clarifying criteria for study continuation at interim analysis.

Anastasia Ivanova, Gary G Koch, Laura E Wiener, 2020, Pharmaceutical statistics.

CHEMARTS & DWoC in the Nakuna Exhibition, organized by Department of Design, ARTS, Milan Design Week 2017, 4.-9.4.2017, Milano, Italy.

Pirjo Kääriäinen, Anastasia Ivanova, Heidi Turunen, 2017 .

Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: a feasibility study.

Anastasia Ivanova, A. Ivanova, J. Boggess, 2012, Gynecologic oncology.

A BIRTH AND DEATH URN FOR RANDOMIZED CLINICAL TRIALS: ASYMPTOTIC METHODS

William F. Rosenberger, Nancy Flournoy, Anastasia Ivanova, 2016 .

Cumulative cohort design for dose-finding

Nancy Flournoy, Yeonseung Chung, Anastasia Ivanova, 2007 .

Comparison of Isotonic Designs for Dose-Finding

Nancy Flournoy, Anastasia Ivanova, 2009, Statistics in biopharmaceutical research.

Dose Finding for Continuous and Ordinal Outcomes with a Monotone Objective Function: A Unified Approach

Anastasia Ivanova, A. Ivanova, Se Hee Kim, 2009, Biometrics.

Detection of Sentinel Nodes for Endometrial Cancer With Robotic Assisted Fluorescence Imaging: Cervical Versus Hysteroscopic Injection

Anastasia Ivanova, A. Ivanova, J. Boggess, 2013, International Journal of Gynecologic Cancer.

A New Dose‐Finding Design for Bivariate Outcomes

Anastasia Ivanova, A. Ivanova, 2003, Biometrics.

Variation in the level of detail in pediatric voiding cystourethrogram reports.

Alejandro Hoberman, Anastasia Ivanova, Anthony J Schaeffer, 2017, Journal of pediatric urology.

Adaptive dose finding based on t‐statistic for dose–response trials

Anastasia Ivanova, Inna Perevozskaya, A. Ivanova, 2008, Statistics in medicine.

Dose finding when the target dose is on a plateau of a dose-response curve: comparison of fully sequential designs.

Anastasia Ivanova, Changfu Xiao, A. Ivanova, 2013, Pharmaceutical statistics.

TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer.

Anastasia Ivanova, Charles M Perou, Katherine A Hoadley, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Optimality, sample size, and power calculations for the sequential parallel comparison design

Anastasia Ivanova, David A Schoenfeld, D. Schoenfeld, 2011, Statistics in medicine.

Bivariate isotonic design for dose‐finding with ordered groups

Anastasia Ivanova, A. Ivanova, Kai Wang, 2006, Statistics in medicine.

Escalation, group and A + B designs for dose‐finding trials

Anastasia Ivanova, A. Ivanova, 2006, Statistics in medicine.

Dose finding with continuous outcome in phase I oncology trials

Anastasia Ivanova, A. Ivanova, Yunfei Wang, 2015, Pharmaceutical statistics.

Two‐Dimensional Dose Finding in Discrete Dose Space

Anastasia Ivanova, A. Ivanova, Kai Wang, 2005, Biometrics.

A play-the-winner-type urn design with reduced variability

Anastasia Ivanova, A. Ivanova, 2003 .

BIAS CALCULATIONS FOR ADAPTIVE URN DESIGNS

Anastasia Ivanova, D. Coad, A. Ivanova, 2001 .